Expert Opinion on Biological Therapy

Overview

Peer reviewed editorials, reviews, drug evaluations and original articles on the discovery, development and clinical application of vaccines, antibodies, stem cells, genetic therapies and hormone or protein-based therapies

Editorial Profile

Aims & Scope: Click here for web site
Editorial Board: Click here for web site
Lead time to online publication (low): 5 weeks
Lead time to online publication (high): 20 weeks
Therapy areas covered include:
  • Cardiology
  • Cell and Molecular Biology
  • Dermatology
  • Diabetes-Metabolism Syndrome
  • Immunology
  • Neurology-Disability-Rehabilitation
  • Oncology-Radiology
  • Ophthalmology
  • Pain
  • Pediatrics
  • Psychiatry-Addictions
  • Reproductive Medicine
  • Respiratory
  • Urology-Nephrology
This journal accepts the following:
  • Clinical Trials
  • Commentaries
  • Editorial
  • Letters
  • Original Research
  • Rapid Communications
  • Review Articles
  • Short Communications
  • Sponsored Supplements
This journal accepts research from the following pipeline phases:
  • Discovery
  • Phase I-II
  • Phase III
  • Phase IV-Post-Launch
  • Pre-Clinical
Clinical trial registration required?: Recommended
Submission/page charges: FastTrack and RapidTrack fees applied to prioritised papers. No charges for StandardTrack or invited papers.

Rapid Publication / Author Services

Services for this journal include:
  • Drug-Clinical Trial Evaluations
  • MEDLINE Indexed
  • Open access option
  • Published online ahead of print
  • Rapid communication articles
  • Rapid publication
  • Supplements-special issues
Colour charges: For illustrations in colour in the hard copy of the journal, the authors are required to pay USD200 for the first page and USD100 for the second and any subsequent pages.
Proof charges: No
Other charges: No
Journal website:
Click here for web site
ISSN: 1471-2598
EISSN: 1744-7682
Editor/s:
Michael Morse
ISI Impact Factor: 3.279
ISI Category Ranking:
42/160 Biotechnology and applied microbiology; 30/106 Medicine, Research and Experimental
ISI Quartile: Q2
Year Established: 2001
Frequency: 12
Rejection Rate: 20%
MEDLINE indexed? Yes
Society Affiliated: No
Official Journal? No
Society:
NA
Monthly Abstract Views: 31085
Print Circulation: NA
Audience: Scientists and researchers in academia, hospital and industry; particularly clinicians, immunologists and molecular biologists
 

Related Journals

an informa business